Informa (LON:INF - Get Free Report) had its target price lowered by equities researchers at Citigroup from GBX 1,000 to GBX 850 in a report released on Thursday,London Stock Exchange reports. The firm currently has a "neutral" rating on the stock. Citigroup's target price suggests a potential upside of 7.57% from the stock's previous close.
Several other analysts also recently commented on the stock. JPMorgan Chase & Co. lowered their target price on shares of Informa from GBX 1,345 to GBX 1,330 and set an "overweight" rating for the company in a report on Monday, January 12th. Berenberg Bank reiterated a "buy" rating and issued a GBX 1,030 target price on shares of Informa in a report on Wednesday, January 21st. Six equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of GBX 1,076.43.
Read Our Latest Report on INF
Informa Stock Performance
INF opened at GBX 790.20 on Thursday. The company has a current ratio of 0.44, a quick ratio of 1.70 and a debt-to-equity ratio of 61.56. The company's fifty day moving average price is GBX 801.12 and its two-hundred day moving average price is GBX 878.91. Informa has a 1-year low of GBX 666 and a 1-year high of GBX 1,000. The company has a market cap of £10.00 billion, a price-to-earnings ratio of 987.75, a PEG ratio of 0.75 and a beta of 0.69.
Informa (LON:INF - Get Free Report) last released its quarterly earnings data on Thursday, March 12th. The company reported GBX 56 earnings per share for the quarter. Informa had a net margin of 1.64% and a return on equity of 0.87%. On average, analysts expect that Informa will post 59.3240265 EPS for the current fiscal year.
Insider Activity at Informa
In other news, insider Stephen A. Carter sold 330,249 shares of the stock in a transaction dated Thursday, January 22nd. The shares were sold at an average price of GBX 934, for a total value of £3,084,525.66. 0.39% of the stock is currently owned by corporate insiders.
About Informa
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.